[Comparative study of clinical features of typical and atypical pneumonias]

M Watari1, H Komagata, M Ohe

  • 1Department of Pulmonary Medicine, Chigasaki Tokushukai General Hospital, Kanagawa, Japan.

Insights

This study on community-acquired pneumonia found age significantly impacts pathogen type, with typical pathogens common in older adults and atypical ones in younger individuals. Initial treatment decisions should consider patient age and illness severity.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Community-acquired pneumonia (CAP) is a significant cause of hospitalization.
  • Identifying causative pathogens is crucial for effective treatment.

Purpose of the Study:

  • To analyze clinical and laboratory features of hospitalized CAP patients.
  • To determine the relationship between patient age and pathogen type in CAP.
  • To inform initial antimicrobial treatment strategies.

Main Methods:

  • Prospective analysis of 74 hospitalized CAP patients.
  • Identification of typical and atypical pathogens.
  • Comparison of clinical and laboratory features based on pathogen type and age.

Main Results:

  • Typical pathogens were more common in older patients (≥60 years), while atypical pathogens predominated in younger patients (<60 years).
  • Atypical pneumonias were more frequent in healthier individuals, associated with symptoms like headache and earache.
  • Typical pneumonias showed higher leukocytosis and C-reactive protein levels.
  • Streptococcus pneumoniae was the most frequent pathogen in severe CAP cases.

Conclusions:

  • Age is a critical factor differentiating typical and atypical pneumonia pathogens.
  • Clinical presentation, including symptoms and lab markers, aids in distinguishing pneumonia types.
  • Tailoring initial antimicrobial therapy based on age, clinical features, and severity is essential for CAP management.

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...